|
Market Closed -
Nasdaq
16:00:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 1.920 USD | -4.95% |
|
+3.78% | +23.08% |
| 09-16 | Novartis halts ALS drug development after mid-stage trial failure | RE |
| 09-15 | Alector, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 07:00 AM |
Transcripts
Search
No results match your criteria
- Stock Market
- Stocks
- ALEC Stock
- News Alector, Inc.
- Transcripts
Select your edition
All financial news and data tailored to specific country editions
















